Development of Novel, First-in-Class Therapeutics to Correct and Augment NAD Homeostasis Grant

Overview

date/time interval

April 1, 2021 - March 31, 2023

awarded by

Metro Mid-Atlantic Biotech, LLC

administered by

missing organization

sponsor award ID

BP 214691-01